Shandong Lukang Pharmaceutical Co.,Ltd. (SHA:600789)

SHA:600789 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	147.64	112.3	394.62	246.17	138.01	89.1
Depreciation & Amortization	437.71	429.43	401.6	381.13	348.12	307.46
Other Amortization	20.21	20.11	0.41	1.44	1.88	2.25
Loss (Gain) From Sale of Assets	-0.12	-0.17	-153.42	-0.28	-2.83	-0.16
Asset Writedown & Restructuring Costs	-20.82	0.18	0.15	-	1	0.68
Loss (Gain) From Sale of Investments	6.01	5.29	7.56	7.2	6.53	3.18
Provision & Write-off of Bad Debts	5.16	5.16	2.52	0.98	8.42	24.39
Other Operating Activities	122.96	109.89	159.56	142.19	163.54	113.83
Change in Accounts Receivable	146.99	169.33	-265.44	-124.56	-516.07	-83.45
Change in Inventory	-67.73	191.09	-145.06	7.62	-314.68	-356.13
Change in Accounts Payable	-36.24	-331.3	-7.36	-53.29	614.77	78.61
Change in Other Net Operating Assets	2.72	3.35	0.69	0.45	-	-
Operating Cash Flow	744.64	698.17	402.82	604.01	444.38	177.49
Operating Cash Flow Growth	40.12%	73.32%	-33.31%	35.92%	150.36%	-24.33%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-367.47	-338.86	-279.18	-337.91	-428.36	-488.57
Sale of Property, Plant & Equipment	93.93	104.2	20.31	0.03	0.15	1.34
Divestitures	-	-	-	2.13	-	-
Investment in Securities	0.03	1.19	-	-	-15.82	-42.18
Other Investing Activities	-	-	-	-34.03	0.03	-4.99
Investing Cash Flow	-273.51	-233.47	-258.87	-369.78	-444.01	-534.4

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Issued	-	1,875	1,676	2,179	2,145	2,577
Total Debt Issued	1,419	1,875	1,676	2,179	2,145	2,577
Long-Term Debt Repaid	-	-1,839	-1,814	-2,198	-1,973	-2,144
Lease Payments	-	-	-	-	-	-0.84
Total Debt Repaid	-1,980	-1,839	-1,814	-2,198	-1,973	-2,144
Net Debt Issued (Repaid)	-560.69	35.98	-137.41	-18.57	171.81	432.68
Issuance of Common Stock	1,187	1,187	17.36	61.88	41.76	1.98
Common Dividends Paid	-79.17	-166.3	-233.49	-143.73	-139.59	-166.39
Other Financing Activities	98.32	99	164.44	6.5	-79.29	-6.95
Financing Cash Flow	645.29	1,156	-189.1	-93.92	-5.31	261.32

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-11.46	2.24	10.81	2.7	6.46	0.83
Net Cash Flow	1,105	1,622	-34.34	143.01	1.52	-94.76

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	377.17	359.31	123.64	266.09	16.02	-311.07
Free Cash Flow Growth	63.30%	190.62%	-53.54%	1561.36%	-	-
Free Cash Flow Margin	6.45%	6.23%	1.98%	4.33%	0.29%	-6.32%
Free Cash Flow Per Share	0.37	0.38	0.14	0.30	0.02	-0.35
Levered Free Cash Flow	695.39	452.7	-278.32	-59	-39.51	-436.35
Unlevered Free Cash Flow	736.51	493.81	-231.21	-9.51	21.77	-395.64
Free Cash Flow After Leases	377.17	359.31	123.64	266.09	16.02	-311.92

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Income Tax Paid	135.93	154.41	130.55	231.16	65.86	104.04
Change in Working Capital	25.87	15.97	-410.17	-174.83	-220.3	-363.25

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 9, 2026

Data Sources Report a data error